Overview
Izamary Waldo-Delgado practices practicing medicine in Tlalpan, Mexico.
Her clinical expertise encompasses Cerebral Hypoxia, Colorectal Cancer, and Cervical Cancer.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Izamary Waldo-Delgado
Is Izamary Waldo-Delgado a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Izamary Waldo-Delgado is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Izamary Waldo-Delgado participate in research or clinical trials?
Yes. Izamary Waldo-Delgado has published 9 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Izamary Waldo-Delgado's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaMs. Waldo-Delgado isExperienced. Learn about Cerebral Hypoxia.
- Cervical CancerMs. Waldo-Delgado isExperienced. Learn about Cervical Cancer.
- Colorectal CancerMs. Waldo-Delgado isExperienced. Learn about Colorectal Cancer.